Jared T. Moore

489 total citations
16 papers, 354 citations indexed

About

Jared T. Moore is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Jared T. Moore has authored 16 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Organic Chemistry, 6 papers in Molecular Biology and 4 papers in Physiology. Recurrent topics in Jared T. Moore's work include Adenosine and Purinergic Signaling (4 papers), Asymmetric Synthesis and Catalysis (4 papers) and Click Chemistry and Applications (2 papers). Jared T. Moore is often cited by papers focused on Adenosine and Purinergic Signaling (4 papers), Asymmetric Synthesis and Catalysis (4 papers) and Click Chemistry and Applications (2 papers). Jared T. Moore collaborates with scholars based in United States, India and Israel. Jared T. Moore's co-authors include Brian M. Stoltz, Jared T. Shaw, Ilan Marek, Pavel Starkov, Justin T. Mohr, James B. Ames, Terrence E. O’Brien, David E. Anderson, Laura L. Lackner and Nohemy A. Sorto and has published in prestigious journals such as Journal of the American Chemical Society, Blood and Cancer Research.

In The Last Decade

Jared T. Moore

16 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jared T. Moore United States 9 226 103 76 40 38 16 354
Caterina Noula Greece 10 202 0.9× 246 2.4× 31 0.4× 56 1.4× 43 1.1× 13 384
Ricardo Lira United States 15 424 1.9× 224 2.2× 56 0.7× 24 0.6× 54 1.4× 26 655
Lee D. Jennings United States 12 441 2.0× 403 3.9× 58 0.8× 23 0.6× 45 1.2× 14 734
David J. Jebaratnam United States 12 322 1.4× 174 1.7× 35 0.5× 21 0.5× 19 0.5× 15 487
Clémence Liébert Germany 11 598 2.6× 77 0.7× 67 0.9× 42 1.1× 23 0.6× 12 684
Sigmond G. Johnson United States 8 342 1.5× 164 1.6× 59 0.8× 20 0.5× 16 0.4× 10 471
Tomoyuki Kimura Japan 14 215 1.0× 309 3.0× 74 1.0× 16 0.4× 35 0.9× 28 598
Florian Glaus Switzerland 10 313 1.4× 144 1.4× 37 0.5× 12 0.3× 43 1.1× 12 440
Adam Mieczkowski Poland 12 384 1.7× 297 2.9× 72 0.9× 10 0.3× 13 0.3× 45 648
Alan X. Xiang United States 10 152 0.7× 170 1.7× 14 0.2× 24 0.6× 54 1.4× 13 367

Countries citing papers authored by Jared T. Moore

Since Specialization
Citations

This map shows the geographic impact of Jared T. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jared T. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jared T. Moore more than expected).

Fields of papers citing papers by Jared T. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jared T. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jared T. Moore. The network helps show where Jared T. Moore may publish in the future.

Co-authorship network of co-authors of Jared T. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Jared T. Moore. A scholar is included among the top collaborators of Jared T. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jared T. Moore. Jared T. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Junttila, Melissa R., Arghya Ray, Robert Warne, et al.. (2022). CD73 Inhibition Reverses Immunosuppression and Has Potential As an Immunomodulatory Therapy in Patients with Multiple Myeloma. Blood. 140(Supplement 1). 9957–9958. 2 indexed citations
2.
Ray, Arghya, Melissa R. Junttila, Ting Du, et al.. (2021). CD73 Inhibition Overcomes Immunosuppression and Triggers Autologous T-Cell Mediated Multiple Myeloma Cell Lysis in the Bone Marrow Milieu. Blood. 138(Supplement 1). 2675–2675. 2 indexed citations
3.
Zavorotinskaya, Tatiana, Brenda Chan, Yuping Chen, et al.. (2020). Abstract 1023: CD73 inhibition with a novel orally bioavailable small molecule blocks adenosine production and rescues T-cells activation. Cancer Research. 80(16_Supplement). 1023–1023. 2 indexed citations
4.
Moore, Jared T., et al.. (2020). Probing Trends in Enantioinduction via Substrate Design: Palladium-Catalyzed Decarboxylative Allylic Alkylation of α-Enaminones. Organic Letters. 22(13). 4966–4969. 10 indexed citations
5.
Du, Xiaohui, Brenda Chan, Xi Chen, et al.. (2020). Abstract 1037: Orally available small molecule CD73 inhibitor reverses immunosuppression through blocking of adenosine production. Cancer Research. 80(16_Supplement). 1037–1037. 1 indexed citations
6.
Moore, Jared T., Kevin Lau, Xiaofeng Xu, Yamin Zhang, & Jason D. Burch. (2019). Enantioselective synthesis of GNE-6688, a potent and selective inhibitor of interleukin-2 inducible T-cell kinase (ITK). Tetrahedron Letters. 60(11). 785–788. 2 indexed citations
7.
Starkov, Pavel, et al.. (2017). Enantioselective Construction of Acyclic Quaternary Carbon Stereocenters: Palladium-Catalyzed Decarboxylative Allylic Alkylation of Fully Substituted Amide Enolates. Journal of the American Chemical Society. 139(28). 9615–9620. 92 indexed citations
8.
Hurley, Katherine A., Thiago M. A. Santos, Madhusudan Rajendran, et al.. (2017). Targeting quinolone- and aminocoumarin-resistant bacteria with new gyramide analogs that inhibit DNA gyrase. MedChemComm. 8(5). 942–951. 5 indexed citations
9.
Mohr, Justin T., Jared T. Moore, & Brian M. Stoltz. (2016). Enantioconvergent catalysis. Beilstein Journal of Organic Chemistry. 12. 2038–2045. 49 indexed citations
10.
Martin, Kévin, Jared T. Moore, Terrence E. O’Brien, et al.. (2015). Synthesis and Evaluation of Quinazolines as Inhibitors of the Bacterial Cell Division Protein FtsZ. ACS Medicinal Chemistry Letters. 6(3). 308–312. 32 indexed citations
11.
Rajendram, Manohary, et al.. (2014). Gyramides Prevent Bacterial Growth by Inhibiting DNA Gyrase and Altering Chromosome Topology. ACS Chemical Biology. 9(6). 1312–1319. 28 indexed citations
12.
Moore, Jared T., et al.. (2013). Enantioselective Synthesis of Isotopically Labeled Homocitric Acid Lactone. Organic Letters. 15(22). 5615–5617. 8 indexed citations
13.
Moore, Jared T., Cristian Soldi, James C. Fettinger, & Jared T. Shaw. (2012). Catalytic alkene cyclization reactions for the stereoselective synthesis of complex “terpenoid-like” heterocycles. Chemical Science. 4(1). 292–296. 27 indexed citations
14.
Anderson, David E., Jared T. Moore, Terrence E. O’Brien, et al.. (2012). Comparison of Small Molecule Inhibitors of the Bacterial Cell Division Protein FtsZ and Identification of a Reliable Cross-Species Inhibitor. ACS Chemical Biology. 7(11). 1918–1928. 68 indexed citations
15.
O’Brien, Terrence E., Jared T. Moore, David E. Anderson, et al.. (2012). The Synthesis and Antimicrobial Activity of Heterocyclic Derivatives of Totarol. ACS Medicinal Chemistry Letters. 3(10). 818–822. 23 indexed citations
16.
Lee, KK & Jared T. Moore. (2010). Configuration Optimization of a Photovoltaic Power Plant in Relation to Cost and Performance. 457–462. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026